GENE SOLUTIONS

Gene Solutions utilizes mitochondrial genomics to identify disease-causing mitochondrial mutations. It represents a breakthrough diagnostic and therapeutic approach to Central Nervous System disease indications. It delivers unique mitochondrial therapeutic solutions and choices for pharmaceutical and biotechnology companies seeking to enhance their drug pipelines in the field of Central Nervous System diseases. Using its unparalleled mitochondrial genetic, therapeutic, and diagnostic expertise – and fortified by its complementary UK and US science teams - it develops and validates leads, binding and cell-based assays, and companion diagnostics for some of the world’s most devastating diseases. It was founded in 2006 and is headquartered in Charlottesville, Virginia.